Structure | Chemical Name | CAS | MF |
|
4(1H)-Pyrimidinone,2-amino-6-methyl-1-(1-methylethyl)-(9CI)
|
133062-62-1
|
C8H13N3O
|
|
bis(di-isobutyloctadecylsiloxy)silicon 2,3-naphthalocyanine
|
133063-13-5
|
C100H134N8O2Si3
|
|
gltS protein, E coli
|
133064-64-9
|
|
|
CCAAT transcription factor EFI(A)
|
133065-13-1
|
C16H28O14
|
|
H-Lys-Pro-AMC
|
133066-53-2
|
C21H28N4O4
|
|
(3R,4S)-2-OXO-4-PHENYLAZETIDIN-3-YL ACETATE
|
133066-59-8
|
C11H11NO3
|
|
PACLITAXEL SIDE CHAIN NO 1
|
133066-61-2
|
C20H21NO4
|
|
N-methylbenperidol
|
133066-70-3
|
C23H26FN3O2
|
|
2-(2-bromoethoxy)-1,1,1-trifluoroethane
|
133068-36-7
|
C4H6BrF3O
|
|
POLY[(2,5-BISOCTYLOXY)-1,4-PHENYLENEVINYLENE]
|
133069-19-9
|
C20H15N3O2
|
|
3-(Piperazin-1-yl)benzo[d]isothiazole dihydrochloride
|
133070-64-1
|
C11H15Cl2N3S
|
|
Benzene, 2-ethoxy-1,4-dinitro- (9CI)
|
133070-80-1
|
C8H8N2O5
|
|
6-Oxabicyclo[3.1.0]hexane-2-carboxamide,2,4-dihydroxy-,(1R,2S,4R,5R)-(9CI)
|
133071-12-2
|
C6H9NO4
|
|
2-Cyclopentene-1-carboxamide,1,4-dihydroxy-,(1S,4R)-(9CI)
|
133071-13-3
|
C6H9NO3
|
|
4-(4-{[(5-methyl-3-isoxazolyl)amino]sulfonyl}anilino)-4-oxobutanoic acid
|
133071-57-5
|
C14H15N3O6S
|
|
5H-Cyclopenta[b]pyridine-7-thiol,6,7-dihydro-(9CI)
|
133073-01-5
|
C8H9NS
|
|
3,N(4)-etheno-3'-deoxyguanosine monophosphate
|
133073-61-7
|
C12H14N5O7P
|
|
METHOTREXATE HYDRATE
|
133073-73-1
|
C20H24N8O6
|
|
Vasopressin, 1-(tetrahydro-4-mercapto-2H-pyran-4-acetic acid)-2-(O-eth yl-D-tyrosine)-4-L-valine-8-L-arginine-
|
133073-75-3
|
C52H75N13O12S2
|
|
(2S)-1-[(10R,13S,16S,19S,22R)-19-benzyl-13-(carbamoylmethyl)-22-[(4-et hoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-16-propan-2-yl-3,7,8-trithi a-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]-N-[(1S)-1- (carbamoylmethylcarbamoyl)-4-(diaminomethylideneamino)butyl]pyrrolidin e-2-carboxamide
|
133073-76-4
|
C52H75N13O11S3
|
|
1-tert-butyl-3-ethoxybenzene
|
133073-81-1
|
C12H18O
|
|
3-(3-FLUORO-PHENOXY)-PROPIONIC ACID
|
133077-42-6
|
C9H9FO3
|
|
bovine ribonuclease peptide (41-61)
|
133080-20-3
|
C100H162N28O32S
|
|
3-Buten-2-ol,4-(2-pyridinyl)-,(E)-(9CI)
|
133080-43-0
|
C9H11NO
|
|
3-Buten-2-ol,4-(4-pyridinyl)-,(E)-(9CI)
|
133080-46-3
|
C9H11NO
|
|
succinimidyl 4-hydrazinobenzoate
|
133081-23-9
|
C11H12ClN3O4
|
|
6-HYDRAZINONICOTINIC ACID
|
133081-24-0
|
C6H7N3O2
|
|
6-[2-(tert-Butoxycarbonyl)hydrazinyl]nicotinic acid
|
133081-25-1
|
C11H15N3O4
|
|
SUCCINIMIDYL 6-BOC-HYDRAZINONICOTINATE
|
133081-26-2
|
C15H18N4O6
|
|
SHNH
|
133081-27-3
|
C10H11ClN4O4
|
|
Cyanamide, 4-pyridinyl- (9CI)
|
133081-43-3
|
C6H5N3
|
|
(1S)-1-(2-CHLOROPHENYL)ETHANE-1,2-DIOL
|
133082-13-0
|
C8H9ClO2
|
|
R-(-)-Manidipine
|
133082-19-6
|
C35H38N4O6
|
|
Cyclohexanimine,5-methyl-2-(1-methylethyl)-,(2S-trans)-(9CI)
|
133082-37-8
|
C10H19N
|
|
N-acetyl-alpha, beta-dehydro-3,4-dihydroxyphenylalanine ethyl ester
|
133083-16-6
|
C13H15NO5
|
|
alpha-(beta-alanyl)hypusine
|
133083-20-2
|
C13H28N4O4
|
|
2-amino-3-(7-methoxy-4-coumaryl)propionic acid
|
133083-29-1
|
C13H13NO5
|
|
N'-(tert-Butoxycarbonyl)-N-(9-fluorenylmethyloxycarbonyl)-D-lysine pentafluorophenyl ester
|
133083-36-0
|
C32H31F5N2O6
|
|
20-fluoromibolerone
|
133083-42-8
|
C20H29FO2
|
|
schweinine
|
133084-04-5
|
C30H40N4O5
|
|
aceratioside
|
133084-09-0
|
C17H22O9
|
|
lyngbyatoxin B
|
133084-52-3
|
C27H39N3O3
|
|
lyngbyatoxin C
|
133084-53-4
|
C27H39N3O3
|
|
H-PHE-ALA-LEU-ALA-LEU-LYS-ALA-LEU-LYS-LYS-ALA-LEU-LYS-LYS-LEU-LYS-LYS-ALA-LEU-LYS-LYS-ALA-LEU-OH
|
133084-63-6
|
C123H226N32O24
|
|
2-AMino-1-Methyl-6-phenyliMidazo[4,5-b]pyridine N-β-D-Glucuronide
|
133084-70-5
|
C19H20N4O6
|
|
BIBS 39
|
133085-33-3
|
C32H36N4O3
|
|
TelMisartan BroMo Ethyl Ester
|
133085-87-7
|
C16H15BrO2
|
|
rhynchotechol
|
133086-78-9
|
C17H14O6
|
|
pallidiflorin
|
133086-79-0
|
C16H12O4
|
|
ganoine
|
133086-80-3
|
C11H17NO2
|
|
ganodine
|
133086-81-4
|
C14H15NO2
|
|
ganoderpurine
|
133086-82-5
|
C11H15N5O
|
|
zijinlongine
|
133086-83-6
|
C21H21NO6
|
|
1-Bromo-7-chloromethyl-3,4-dichloro-3-methyl-1,5,7-octatriene
|
133086-86-9
|
C9H10BrCl3
|
|
funebradiol
|
133086-87-0
|
C12H15NO4
|
|
2-Chloro-5-methoxy-4-methyl-phenylamine
|
133088-44-5
|
C8H10ClNO
|
|
7-Quinolinamine,5,6,7,8-tetrahydro-(9CI)
|
133091-81-3
|
C9H12N2
|
|
Quinoline, 5,6-dihydro-4-methyl- (9CI)
|
133092-25-8
|
C10H11N
|
|
Quinoline, 5,6-dihydro-3-methyl- (9CI)
|
133092-30-5
|
C10H11N
|
|
4-Chloro-5,6,7,8-tetrahydroquinoline
|
133092-34-9
|
C9H10ClN
|
|
1-Piperazinecarboxaldehyde, 4-(2-aminoethyl)- (9CI)
|
133093-79-5
|
C7H15N3O
|
|
diisopropyl pyridine-2,3-dicarboxylate
|
133093-99-9
|
C13H17NO4
|
|
(S)-1-TOSYLOXY-3-BUTEN-1-OL
|
133095-74-6
|
C11H14O4S
|
|
3,4,5-TRIMETHOXYPHENYLMAGNESIUM BROMIDE SOLUTION 0.5M IN TETRAHYDROFURAN
|
133095-91-7
|
C9H11BrMgO3
|
|
1-(4-aminobenzyl)-DTPA
|
133097-22-0
|
C21H34Cl4N4O10
|
|
1-(6-methoxy-2-naphthyl)ethanamine
|
133097-30-0
|
C13H15NO
|
|
(1R,4R)-2-Methyl-2,5-diazabicyclo[2.2.1]heptane
|
133097-95-7
|
C6H12N2
|
|
R-(-)-Isoflurane
|
133098-04-1
|
C3H2ClF5O
|
|
S-(+)-Isoflurane
|
133098-05-2
|
C3H2ClF5O
|
|
Darifenacin
|
133099-04-4
|
C28H30N2O2
|
|
DARIFENACIN
|
133099-05-5
|
C28H30N2O2
|
|
Darifenacin hydrobromide
|
133099-07-7
|
C28H31BrN2O2
|
|
(S)-3-(1-Cyano-1,1-diphenylmethyl)-1-tosylpyrrolidine
|
133099-09-9
|
C25H24N2O2S
|
|
(S)-alpha,alpha-Diphenyl-3-pyrrolidineacetamide
|
133099-11-3
|
C18H18N2
|
|
(R)-2,2-diphenyl-2-(pyrrolidin-3-yl)acetonitrile
|
133099-12-4
|
C18H18N2
|
|
4(1H)-Pyrimidinethione, 2-mercapto- (9CI)
|
133099-49-7
|
C4H4N2S2
|
|
N-(phenylacetyl)glycylaziridine-2-carboxylate phenylmethyl ester
|
133099-77-1
|
C20H20N2O4
|
|
H-D-Ser-Obzl Hydrochloride salt
|
133099-79-3
|
C10H13NO3
|
|
D-SERINE BENZYL ESTER PTSA
|
133099-80-6
|
C17H21NO6S
|
|
Indeno[5,6-d]imidazole, 1,5,6,7-tetrahydro-2-methyl- (9CI)
|
133100-20-6
|
C11H12N2
|
|
Indeno[5,6-d]imidazol-2-amine, 1,5,6,7-tetrahydro- (9CI)
|
133100-21-7
|
C10H11N3
|
|
4-BROMO-3-METHYL-ISOQUINOLINE
|
133100-87-5
|
C10H8BrN
|
|
6-glucopyranosyl 3'-azido-3'-deoxy-5'-thymidinyl phosphate
|
133101-34-5
|
C16H24N5O12P
|
|
H-TRP-SER-OH
|
133101-40-3
|
C14H17N3O4
|
|
Elastins, esters with hydroxy-terminated hydroxy Me siloxanes
|
133101-79-8
|
|
|
Siloxanes and Silicones, di-Me, ethoxy Me, ethoxy Ph, polymers with Me silsesquioxanes and Ph silsesquioxanes, ethoxy-terminated
|
133101-81-2
|
|
|
Ethanol, 2-(2-aminoethyl)amino-, reaction products with polybutene
|
133101-86-7
|
|
|
YCR521 protein
|
133105-78-9
|
|
|
DKP-insulin
|
133107-49-0
|
|
|
INSULIN LISPRO (5.97 MG)
|
133107-64-9
|
C257H383N65O77S6
|
|
hemoglobin Iowa
|
133108-59-5
|
|
|
Pediocin Pediococcus acidilactici
|
133108-87-9
|
|
|
6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine
|
133111-56-5
|
C21H20ClN
|
|
4-BROMO-3-(2,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE
|
133112-51-3
|
C10H7BrCl2N2
|
|
5-CHLORO-3-(2,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE
|
133112-53-5
|
C10H7Cl3N2
|
|
3-(2,4-Dichlorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid
|
133113-04-9
|
C11H8Cl2N2O2
|
|
DiMethyl 2-(1,3-Dithiole)phosphonate
|
133113-76-5
|
C5H9O3PS2
|
|
3-(3-M-TOLYL-UREIDO)-PROPIONIC ACID
|
133115-50-1
|
C11H14N2O3
|
|
(3-TRIFLUOROMETHOXY-PHENYL)-HYDRAZINE HYDROCHLORIDE
|
133115-55-6
|
C7H8ClF3N2O
|
|
4-(Trifluoromethoxy)phenylhydrazine hydrochloride
|
133115-72-7
|
C7H8ClF3N2O
|